Our Equity Capital Markets team has recently advised Beaumont Cornish and CMC markets on the readmission of Ovoca Bio Ltd (to be renamed Talisman Metals plc) to AIM, together with an associated placing.
Readmission to AIM was sought in connection with the reverse takeover of Ovoca Bio which resulted from its acquisition of Tadeen International Ltd – a UK company focused, through its wholly-owned subsidiary Horizons Mines SARL, on the development of a portfolio of mineral exploration licences. The business has a primary focus on copper mineralisation in Morocco.
Beaumont Cornish acted as nominated adviser to Talisman Metals in relation to the transaction, with CMC Markets acting as broker to the company.
Talisman Metals shares were readmitted to trading on 28 January 2026 with a market capitalisation on readmission of approximately £4.9 million.
Our Equity Capital Markets team, led by Partner Sam Hudson and Senior Associate Amelia Chung, acted on the transaction.
We are delighted to have supported the nominated adviser and broker on Talisman Metals’ readmission, and we look forward to following Talisman Metals’ story as they seek to implement their exploration programme.Sam Hudson
Partner at Hill Dickinson
Sam Hudson, Partner at Hill Dickinson, said: “We are delighted to have supported the nominated adviser and broker on Talisman Metals’ readmission, and we look forward to following Talisman Metals’ story as they seek to implement their exploration programme.
“2026 has got off to a flying start for our ECM team with significant transactions completed across each of the Main Market, AIM and Aquis in January alone. We have many more significant transactions in the pipeline which gives us renewed confidence of a continued uptick in UK capital markets over the forthcoming year.”